Fanping Meng

100 Western 4th Ring Road
Beijing, 100039, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Correction: Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemia.

Correction: Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemia.

Journal: Frontiers in immunology

Published: April 16, 2026

Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemia.

Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemia.

Journal: Frontiers in immunology

Published: January 19, 2026

Phase-specific polarization of peripheral helper T cells influences immunopathology and viral control in HBV infection.

Phase-specific polarization of peripheral helper T cells influences immunopathology and viral control in HBV infection.

Journal: Hepatology international

Published: January 06, 2026

Current status of nurses' public health emergency response capacity for emerging infectious disease: a cross-sectional study.

Current status of nurses' public health emergency response capacity for emerging infectious disease: a cross-sectional study.

Journal: Frontiers in public health

Published: April 24, 2025

Dose-escalation studies of mesenchymal stromal cell therapy for decompensated liver cirrhosis: phase Ia/Ib results and immune modulation insights.

Dose-escalation studies of mesenchymal stromal cell therapy for decompensated liver cirrhosis: phase Ia/Ib results and immune modulation insights.

Journal: Signal transduction and targeted therapy

Published: January 19, 2025

Cadonilimab, a PD-1/CTLA-4 bispecific antibody in unresectable hepatocellular carcinoma: a real-world study.

Cadonilimab, a PD-1/CTLA-4 bispecific antibody in unresectable hepatocellular carcinoma: a real-world study.

Journal: Cancer immunology, immunotherapy : CII

Published: November 29, 2024

Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinemia: a retrospective cohort study.

Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinemia: a retrospective cohort study.

Journal: Frontiers in immunology

Published: November 19, 2024

Early Alpha-Fetoprotein Response Predicts Sustained Tumor Response Following Immune Checkpoint Inhibitors Combined with Targeted Therapy in Liver Cancer.

Early Alpha-Fetoprotein Response Predicts Sustained Tumor Response Following Immune Checkpoint Inhibitors Combined with Targeted Therapy in Liver Cancer.

Journal: Biomedicines

Published: November 11, 2024

Preclinical and phase I studies of an antisense oligonucleotide drug targeting IGF-1R in liver cancer.

Preclinical and phase I studies of an antisense oligonucleotide drug targeting IGF-1R in liver cancer.

Journal: Future oncology (London, England)

Published: April 04, 2024

Activation of CD14+ Monocytes via the IFN-γ Signaling Pathway Is Associated with Immune-Related Adverse Events in Hepatocellular Carcinoma Patients Receiving PD-1 Inhibition Combination Therapy.

Activation of CD14+ Monocytes via the IFN-γ Signaling Pathway Is Associated with Immune-Related Adverse Events in Hepatocellular Carcinoma Patients Receiving PD-1 Inhibition Combination Therapy.

Journal: Biomedicines

Published: March 29, 2024

Omicron neutralization character in patients with breast cancer and liver cancer after the nationwide omicron outbreak.

Omicron neutralization character in patients with breast cancer and liver cancer after the nationwide omicron outbreak.

Journal: Cancer medicine

Published: February 13, 2024

Detection of minimal hepatic encephalopathy in patients with cirrhosis based on the Stroop-CN model (NCRCID-CHESS 2106): a prospective multicenter study.

Detection of minimal hepatic encephalopathy in patients with cirrhosis based on the Stroop-CN model (NCRCID-CHESS 2106): a prospective multicenter study.

Journal: MedComm

Published: October 06, 2023

Showing 1-12 of 40

Last Updated: 09/26/2026